Family Medicine · Carmel, IN
NPI
1932317849
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
14828 Greyhound Ct Ste 100
Carmel, IN, 46032
Phone (317) 582-9224
Groups this clinician bills Medicare through
Medicare paid, 2024
$66K
879 services
Medicare patients, 2024
420
Average age 75
Drug cost, 2024
$799K
10,493 prescriptions
Company payments, 2025
$733
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark R Freije was code 99214 (office e&m - established), 238 times for 186 patients. In total Mark R Freije billed 879 services in 36 codes, and Medicare paid $66K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 238 | 186 | $75.31 | $18K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 219 | 219 | $120.24 | $26K |
| 99213 Office E&M - Established | Office | 120 | 94 | $51.00 | $6,120 |
| G0008 Administration of influenza virus vaccine | Office | 36 | 36 | $24.50 | $882 |
| 90662 Vaccine Product | Office | 34 | 34 | $81.82 | $2,782 |
| 36415 Venipuncture Blood Collection | Office | 27 | 27 | $8.65 | $234 |
| 99204 Office E&M - New | Office | 22 | 22 | $79.07 | $1,739 |
| 99212 Office E&M - Established | Office | 12 | 11 | $38.06 | $457 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 11 | 11 | $153.98 | $1,694 |
By year: 2022 $52K for 880 services; 2023 $59K for 900 services; 2024 $66K for 879 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 27 | 27 | $8.65 | $234 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark R Freije prescribed most often to Medicare patients was Atorvastatin Calcium, with 648 prescriptions and refills. In total Mark R Freije wrote 10,493 Medicare prescriptions that cost $799K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 648 | 1,870 | 190 | $3,779 |
| Levothyroxine Sodium Generic | 504 | 1,380 | 134 | $3,723 |
| Amlodipine Besylate Generic | 385 | 1,101 | 116 | $2,049 |
| Lisinopril Generic | 288 | 782 | 82 | $1,755 |
| Losartan Potassium Generic | 272 | 818 | 83 | $1,962 |
| Metoprolol Succinate Generic | 256 | 736 | 75 | $2,301 |
| Tamsulosin Hcl Generic | 223 | 629 | 66 | $2,647 |
| Rosuvastatin Calcium Generic | 218 | 648 | 71 | $1,854 |
| Simvastatin Generic | 217 | 586 | 53 | $1,233 |
| Pantoprazole Sodium Generic | 212 | 505 | 55 | $2,351 |
| Omeprazole Generic | 204 | 560 | 63 | $2,227 |
| Metformin Hcl Generic | 192 | 540 | 53 | $1,036 |
| Hydrochlorothiazide Generic | 183 | 512 | 55 | $705 |
| Allopurinol Generic | 167 | 466 | 49 | $859 |
| Gabapentin Generic | 151 | 305 | 46 | $2,096 |
Brand drugs: 1,007 claims; generic drugs: 9,441 claims; opioid claims: 253.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark R Freije $733 ($733 in general payments such as food, travel and fees) from 17 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $136.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 7 | $136 |
| Novo Nordisk Inc NVO | 7 | $127 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $64.35 |
| Corium, LLC | 4 | $63.77 |
| Abbvie Inc. ABBV | 2 | $51.6 |
| Pfizer Inc. PFE | 2 | $37.77 |
| Abbott Laboratories ABT | 2 | $37.36 |
| Exact Sciences Corporation EXAS | 2 | $35.93 |
| GlaxoSmithKline, LLC. GSK | 2 | $32.97 |
| Amgen Inc. AMGN | 1 | $24.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.